Drug
Tetrahydrobiopterin
Tetrahydrobiopterin is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
67%(2 trials)
Phase Distribution
Ph phase_1
2
33%
Ph phase_2
3
50%
Ph early_phase_1
1
17%
Phase Distribution
3
Early Stage
3
Mid Stage
0
Late Stage
Phase Distribution6 total trials
Early Phase 1First-in-human
1(16.7%)
Phase 1Safety & dosage
2(33.3%)
Phase 2Efficacy & side effects
3(50.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
75.0%
3 of 4 finished
Non-Completion Rate
25.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(3)
Terminated(1)
Other(2)
Detailed Status
Completed3
unknown2
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Early Phase 11 (16.7%)
Phase 12 (33.3%)
Phase 23 (50.0%)
Trials by Status
completed350%
unknown233%
withdrawn117%
Recent Activity
0 active trials
Showing 5 of 6
withdrawnphase_1
O2 Transport and Utilization in Health and Lung Disease
NCT04014712
unknownphase_2
A Study for Assessing the Efficacy and Safety of BH4 in Radiation Enteritis
NCT05138887
unknownphase_1
A Study for Assessing the Efficacy and Safety of Tetrahydrobiopterin in Radiation-Induced Skin Injury
NCT05114226
completedphase_2
Endothelial Facilitation in Alzheimer's Disease
NCT01439555
completedphase_2
Exercise Intolerance in Renal Failure
NCT01356966
Clinical Trials (6)
Showing 6 of 6 trials
NCT04014712Phase 1
O2 Transport and Utilization in Health and Lung Disease
NCT05138887Phase 2
A Study for Assessing the Efficacy and Safety of BH4 in Radiation Enteritis
NCT05114226Phase 1
A Study for Assessing the Efficacy and Safety of Tetrahydrobiopterin in Radiation-Induced Skin Injury
NCT01439555Phase 2
Endothelial Facilitation in Alzheimer's Disease
NCT01356966Phase 2
Exercise Intolerance in Renal Failure
NCT00208780Early Phase 1
Effects of Tetrahydrobiopterin on Blood Pressure
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6